Onconic Therapeutics Inc.
Clinical trials sponsored by Onconic Therapeutics Inc., explained in plain language.
-
New drug combo aims to fight tough pancreatic cancer
Disease control Recruiting nowThis study tests a new drug called JPI-547, taken as a pill, together with standard chemotherapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to find the safest dose and see if the combination helps shrink tumors or slow the disease. A…
Phase: PHASE1, PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug safety check: how does JP-1366 mix with heart meds?
Knowledge-focused Recruiting nowThis early-stage study is checking if a new drug called JP-1366 is safe when taken with common heart medications like clopidogrel, aspirin, atorvastatin, and apixaban. About 96 healthy adults will take part to see how these drugs interact in the body. The goal is to gather import…
Phase: PHASE1 • Sponsor: Onconic Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC